CYAD

Celyad Oncology SA American Depositary Shares

Delisted

CYAD was delisted on the 18th of May, 2023.

9 hedge funds and large institutions have $11.4M invested in Celyad Oncology SA American Depositary Shares in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Victory Capital Management
1
Victory Capital Management
Texas
$10.4M +$477K +45,778 +5%
Morgan Stanley
2
Morgan Stanley
New York
$395K +$162K +15,494 +69%
Wells Fargo
3
Wells Fargo
California
$224K +$135K +12,913 +150%
Millennium Management
4
Millennium Management
New York
$187K -$334K -32,048 -64%
Jane Street
5
Jane Street
New York
$117K +$117K +10,790 New
UBS Group
6
UBS Group
Switzerland
$32K +$22.6K +2,166 +241%
Deutsche Bank
7
Deutsche Bank
Germany
$17K +$17K +1,676 New
PA
8
PSI Advisors
Florida
$7K +$7K +700 New
Bank of Montreal
9
Bank of Montreal
Ontario, Canada
$1K
Zurich Cantonal Bank
10
Zurich Cantonal Bank
Switzerland
-$1K -100 Closed